Five Prime Therapeutics Inc (FPRX) - Financial and Strategic SWOT Analysis Review

  • ID: 4282209
  • SWOT Analysis
  • 54 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Akebia Therapeutics Inc
  • Ardelyx Inc
  • CytRx Corp
  • Fortress Biotech Inc
  • MORE
Five Prime Therapeutics Inc (FPRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Five Prime Therapeutics Inc (Five Prime) is a clinical state is a biopharmaceutical company focusing on the research and development of novel treatments for cancer and inflammatory disorders. The company’s developmental pipeline is based on the discovery platform and library of therapeutic proteins. The company’s pipeline products include cabiralizumab, for pigmented villonodular synovitis and for multiple cancers; FPA144 for gastric cancer; and FP-1039 for the treatment of patients with malignant pleural mesothelioma. Five Prime has also developed proprietary protein screening technologies and rapid in vivo protein production system to identify new targets for protein therapeutics. The company has development collaborations with companies such as Bristol-Myers Squibb, GlaxoSmithKline and UCB Pharma. Five Prime is headquartered in South San Francisco, California, the US.

Five Prime Therapeutics Inc Key Recent Developments

Aug 17,2017: Five Prime Therapeutics Announces Addition of Bryan Irving, PhD, as Senior Vice President, Research
Aug 08,2017: Five Prime Announces Second Quarter 2017 Results and Provides Business Update
Jun 21,2017: Five Prime Therapeutics Announces Lewis T. “Rusty” Williams Plans to Transition from CEO to Executive Chairman of the Board in 2018
May 15,2017: Five Prime Welcomes Garry Nicholson to Board of Directors
May 04,2017: Five Prime Announces First Quarter 2017 Results and Provides Business Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Akebia Therapeutics Inc
  • Ardelyx Inc
  • CytRx Corp
  • Fortress Biotech Inc
  • MORE
Section 1 - About the Company
  • Five Prime Therapeutics Inc - Key Facts
  • Five Prime Therapeutics Inc - Key Employees
  • Five Prime Therapeutics Inc - Key Employee Biographies
  • Five Prime Therapeutics Inc - Major Products and Services
  • Five Prime Therapeutics Inc - History
  • Five Prime Therapeutics Inc - Company Statement
  • Five Prime Therapeutics Inc - Locations And Subsidiaries
  • Head Office
Section 2 - Company Analysis
  • Five Prime Therapeutics Inc - Business Description
  • Five Prime Therapeutics Inc - Corporate Strategy
  • Five Prime Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Five Prime Therapeutics Inc - Strengths
  • Five Prime Therapeutics Inc - Weaknesses
  • Five Prime Therapeutics Inc - Opportunities
  • Five Prime Therapeutics Inc - Threats
  • Five Prime Therapeutics Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Five Prime Therapeutics Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Aug 17, 2017: Five Prime Therapeutics Announces Addition of Bryan Irving, PhD, as Senior Vice President, Research
  • Aug 08, 2017: Five Prime Announces Second Quarter 2017 Results and Provides Business Update
  • Jun 21, 2017: Five Prime Therapeutics Announces Lewis T. “Rusty” Williams Plans to Transition from CEO to Executive Chairman of the Board in 2018
  • May 15, 2017: Five Prime Welcomes Garry Nicholson to Board of Directors
  • May 04, 2017: Five Prime Announces First Quarter 2017 Results and Provides Business Update
  • Apr 03, 2017: Five Prime Presents Data on Unique Immuno-Oncology Discovery Research at the 2017 AACR Annual Meeting
  • Mar 20, 2017: Five Prime Therapeutics Announces Executive Changes
  • Feb 23, 2017: Five Prime Announces Fourth Quarter and Full Year 2016 Financial Results
  • Nov 03, 2016: Five Prime Announces Third Quarter 2016 Results and Provides Business Update
  • Sep 20, 2016: Five Prime Therapeutics Announces Key Executive Promotions
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Five Prime Therapeutics Inc, Key Facts
  • Five Prime Therapeutics Inc, Key Employees
  • Five Prime Therapeutics Inc, Key Employee Biographies
  • Five Prime Therapeutics Inc, Major Products and Services
  • Five Prime Therapeutics Inc, History
  • Five Prime Therapeutics Inc, Key Competitors
  • Five Prime Therapeutics Inc, Ratios based on current share price
  • Five Prime Therapeutics Inc, Annual Ratios
  • Five Prime Therapeutics Inc, Annual Ratios (Cont...1)
  • Five Prime Therapeutics Inc, Interim Ratios
  • Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Five Prime Therapeutics Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Five Prime Therapeutics Inc, Performance Chart (2012 - 2016)
  • Five Prime Therapeutics Inc, Ratio Charts
  • Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Rexahn Pharmaceuticals Inc
  • Fortress Biotech Inc
  • CytRx Corp
  • Ardelyx Inc
  • Akebia Therapeutics Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll